# Effects of Metreleptin in Type 1 Diabetes Mellitus

> **NCT01268644** · PHASE1 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 8 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Leptin

## Key facts

- **NCT ID:** NCT01268644
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2013-01
- **Final completion:** 2014-08
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Sponsor request
- **Last updated:** 2019-08-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01268644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01268644, "Effects of Metreleptin in Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01268644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*